We know there are a lot of questions that come with a new FDA approved medication! We hope to answer a few that may be top of mind about Rezdiffra.

1. What is Rezdiffra? A new drug called Rezdiffra shows promising results in treating Nonalcoholic Steatohepatitis (NASH), now known as Metabolic Dysfunction-Associated Steatohepatitis (MASH), a liver condition that can lead to serious complications like cirrhosis and liver cancer, providing an amazing opportunity for improved patient care.
2.  
3. What’s the big deal? The availability of the first NASH/MASH drug, Rezdiffra, marks a significant advancement in the treatment landscape for NASH, offering hope for improved liver health and overall outcomes.
4.  
5. Who can take Rezdiffra? Rezdiffra is for patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with moderate to advanced liver fibrosis.
6.  
7. Are there side effects? Like all medicines, Rezdiffra can have some side effects. Some people experienced nausea or diarrhea more often than those who took a placebo (a pill with no medicine in it). However, serious side effects were rare, which is reassuring.
8.  
9. Who can I call to talk to about Rezdiffra? The team at Arizona Liver Health is well-equipped to answer any questions about Rezdiffra, and to help determine if Rezdiffra is the right choice for you!  Call us to schedule an appointment with one of our knowledgeable providers.